MX2014001368A - Soluciones anti-inflamatorias estables para inyección. - Google Patents

Soluciones anti-inflamatorias estables para inyección.

Info

Publication number
MX2014001368A
MX2014001368A MX2014001368A MX2014001368A MX2014001368A MX 2014001368 A MX2014001368 A MX 2014001368A MX 2014001368 A MX2014001368 A MX 2014001368A MX 2014001368 A MX2014001368 A MX 2014001368A MX 2014001368 A MX2014001368 A MX 2014001368A
Authority
MX
Mexico
Prior art keywords
injection
stable anti
inflammatory
inflammatory solutions
solutions
Prior art date
Application number
MX2014001368A
Other languages
English (en)
Other versions
MX347373B (es
Inventor
Wayne R Gombotz
Gregory A Demopulos
Hui-Rong Shen
Original Assignee
Omeros Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47627326&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2014001368(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Omeros Corp filed Critical Omeros Corp
Publication of MX2014001368A publication Critical patent/MX2014001368A/es
Publication of MX347373B publication Critical patent/MX347373B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Abstract

La presente invención se relaciona con formulaciones de líquido estable de ketoprofeno, amitriptilina y oximetazolina.
MX2014001368A 2011-08-04 2012-08-03 Soluciones anti-inflamatorias estables para inyección. MX347373B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161515234P 2011-08-04 2011-08-04
PCT/US2012/049463 WO2013020021A1 (en) 2011-08-04 2012-08-03 Stable anti-inflammatory solutions for injection

Publications (2)

Publication Number Publication Date
MX2014001368A true MX2014001368A (es) 2014-06-11
MX347373B MX347373B (es) 2017-04-25

Family

ID=47627326

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014001368A MX347373B (es) 2011-08-04 2012-08-03 Soluciones anti-inflamatorias estables para inyección.

Country Status (21)

Country Link
US (3) US20130035362A1 (es)
EP (1) EP2739266B1 (es)
JP (2) JP6174579B2 (es)
KR (1) KR101951064B1 (es)
CN (1) CN103957886B (es)
AR (1) AR089203A1 (es)
AU (1) AU2012289968B2 (es)
BR (1) BR112014002631B1 (es)
CA (1) CA2844152C (es)
CL (1) CL2014000267A1 (es)
DK (1) DK2739266T3 (es)
ES (1) ES2600153T3 (es)
HK (1) HK1198911A1 (es)
IL (1) IL230779B (es)
MX (1) MX347373B (es)
NZ (1) NZ621484A (es)
PL (1) PL2739266T3 (es)
PT (1) PT2739266T (es)
RU (1) RU2635521C2 (es)
WO (1) WO2013020021A1 (es)
ZA (1) ZA201401344B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3119755A1 (en) 2013-03-15 2014-09-18 Tonix Pharma Holdings Limited Eutectic formulations of amitriptyline hydrochloride and mannitol
WO2016014408A1 (en) * 2014-07-21 2016-01-28 Board Of Regents, The University Of Texas System Formulations of intraarticular pharmaceutical agents and methods for preparing and using the same
TWI705812B (zh) 2014-12-01 2020-10-01 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
US20170049134A1 (en) * 2015-08-18 2017-02-23 Empire Technology Development Llc Meat tendering using food grade natural products for reducing muscle contraction
JP7023690B2 (ja) 2017-12-06 2022-02-22 株式会社東芝 道路維持管理システム、道路維持管理方法及びコンピュータプログラム
US20220347122A1 (en) * 2019-03-15 2022-11-03 Ftf Pharma Private Limited Solutions for oral dosage
WO2021084730A1 (ja) 2019-11-01 2021-05-06 三菱電機株式会社 劣化状態判定装置、劣化状態検査システム、及び、劣化状態検査方法
FR3123563A1 (fr) * 2021-06-03 2022-12-09 Algotherapeutix Utilisation de l’amitriptyline et/ou l’un de ses sels pharmaceutiquement acceptable comme agent conservateur
CN116165306B (zh) * 2023-04-25 2023-11-17 湖南九典制药股份有限公司 酮洛芬凝胶贴膏中有关物质的分析测定方法及应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624893A (en) * 1993-10-14 1997-04-29 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
IT1269583B (it) * 1994-04-26 1997-04-08 Bayer Italia Spa Preparazioni farmaceutiche a base di una soluzione di ketoprofene in capsule di gelatina molle e metodo per la loro produzione
ATE300308T1 (de) * 1994-12-12 2005-08-15 Omeros Corp Bespüllungslösung und deren verwendung zur perioperativen hemmung von schmerzen, entzündungen und spasmen an einer wunde
KR100517210B1 (ko) 1994-12-12 2006-06-07 오메로스 코포레이션 통증,염증및경련억제용관주용액
US7091181B2 (en) * 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
IT1277741B1 (it) * 1995-12-28 1997-11-12 Dompe Spa Composizioni farmaceutiche parenterali contenenti sali di alchilammonio di acidi 2-arilpropionici
US7973068B2 (en) * 1998-10-20 2011-07-05 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
US7022740B2 (en) * 2004-04-29 2006-04-04 Leonard Mackles Lubricious ophthalmic solutions
US20070053868A1 (en) * 2005-03-08 2007-03-08 Banner Pharmacaps, Inc. Solvent system for enhancing the solubility of pharmaceutical agents
ES2614474T3 (es) * 2005-05-20 2017-05-31 Omeros Corporation Composiciones que comprenden ketoprofeno y un antagonista de los canales de calcio para usar en procedimientos urológicos
US20070207222A1 (en) * 2006-03-01 2007-09-06 Tristrata, Inc. Composition and method for topical treatment of tar-responsive dermatological disorders
EP2117513A2 (en) * 2007-02-05 2009-11-18 Carbylan Biosurgery, Inc. Polymer formulations for delivery of bioactive agents
WO2008115572A1 (en) * 2007-03-21 2008-09-25 Theraquest Biosciences, Inc. Methods and compositions of nsaids
US20120208858A1 (en) * 2011-02-15 2012-08-16 Allergan, Inc. Pharmaceutical Cream Compositions of Oxymetazoline and Methods of Use

Also Published As

Publication number Publication date
PT2739266T (pt) 2016-10-04
US20160166696A1 (en) 2016-06-16
JP2017014288A (ja) 2017-01-19
BR112014002631B1 (pt) 2022-04-19
CA2844152C (en) 2020-04-14
HK1198911A1 (zh) 2015-06-19
KR20140057579A (ko) 2014-05-13
RU2014108159A (ru) 2015-09-10
CN103957886B (zh) 2016-03-30
CA2844152A1 (en) 2013-02-07
RU2635521C2 (ru) 2017-11-13
US20180344855A1 (en) 2018-12-06
CN103957886A (zh) 2014-07-30
NZ621484A (en) 2016-05-27
PL2739266T3 (pl) 2017-07-31
WO2013020021A1 (en) 2013-02-07
KR101951064B1 (ko) 2019-02-21
EP2739266B1 (en) 2016-07-27
US20130035362A1 (en) 2013-02-07
JP6174579B2 (ja) 2017-08-02
EP2739266A1 (en) 2014-06-11
AU2012289968A1 (en) 2013-03-28
ZA201401344B (en) 2016-10-26
CL2014000267A1 (es) 2014-08-29
IL230779B (en) 2019-05-30
AR089203A1 (es) 2014-08-06
ES2600153T3 (es) 2017-02-07
MX347373B (es) 2017-04-25
EP2739266A4 (en) 2014-12-31
JP2014521694A (ja) 2014-08-28
AU2012289968B2 (en) 2014-01-16
DK2739266T3 (en) 2016-10-03
IL230779A0 (en) 2014-03-31
BR112014002631A2 (pt) 2017-03-07

Similar Documents

Publication Publication Date Title
MX347373B (es) Soluciones anti-inflamatorias estables para inyección.
PH12015500850A1 (en) Stable preservative-free mydriatic and anti-inflammatory solutions for injection
UY34587A (es) Formulaciones estabilizadas que contienen anticuerpos antiang2
DK2882850T3 (da) System for preparation of adipose-derived stem cells
CL2014003370A1 (es) Composición acuosa estable de anticuerpos anti-baffr; y dispositivo de suministro de la composición.
AU2012265219A8 (en) Compounds containing hydrido-tricyano-borate anions
BR112015004936A2 (pt) composição farmacêutica revestida contendo regorafenib
CR20130539A (es) Triazolopiridinas
GEP201706710B (en) Imidazopyridazine derivatives as gabaa receptor modulators
EP2852588B8 (en) Hydantoin derivatives as kv3 inhibitors
IT1402018B1 (it) Formulazioni per il trattamento delle affezioni delle prime vie respiratorie.
CO7151478A2 (es) Formulaciones estabilizadas que contienen anticuerpos anti-dll4
CO6920289A2 (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib.
CO7141434A2 (es) Nueva forma de dosificación formulación de abediterol
ITTO20110268A1 (it) Composizione di maquillage.
MX351610B (es) Sales acidas de adicion de 5alfa-hidroxi-6beta-[2-(1h-imidazol-4-i l)etilamino]colestan-3beta-ol.
UY34154A (es) Dosificación y administración de anticuerpos anti-erbb3 en combinación con paclitaxel.
IT1399492B1 (it) Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina.
EA201500313A1 (ru) Стабилизированная аморфная форма агомелатина, способ ее изготовления и фармацевтические композиции, ее содержащие
EA201492280A1 (ru) Стабильный состав пексиганана
EA201400444A1 (ru) Производные 2-оксопиперидинила
BR112013027391A2 (pt) formulação farmacêutica, frasco e kit
BR112013027390A2 (pt) formulação farmacêutica
BR112013025766A2 (pt) composições farmacêuticas de liberação modificada de desvenlafaxina
TH1201001042B (th) สูตรผสมเชิงเภสัชกรรมที่เข้มข้นสูง, ซึ่งเสถียรของแอนติ-CD20 แอนติบอดี (anti-CD20 antibody)

Legal Events

Date Code Title Description
FG Grant or registration